127 related articles for article (PubMed ID: 35129463)
21. The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer.
Zamcheck N
Clin Gastroenterol; 1976 Sep; 5(3):625-38. PubMed ID: 1022377
[No Abstract] [Full Text] [Related]
22. [The mistakes in diagnosis of pancreatic intraductal papillary mucinous tumor].
Gorin DS; Zakharova MA; Smirnov AV; Kriger AG
Khirurgiia (Mosk); 2019; (2):96-100. PubMed ID: 30855598
[TBL] [Abstract][Full Text] [Related]
23. A case of pancreatic cancer as a recurrence of intraductal papillary mucinous neoplasm following surgical resection.
Choi SB; Jo HS; Choi SY
JOP; 2014 Jul; 15(4):411-2. PubMed ID: 25076356
[No Abstract] [Full Text] [Related]
24. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
25. [Myofibroblastic inflammatory tumor simulating recurrence of pancreatic vipoma].
Padilla D; Cubo T; Ramia JM; Pardo R; Ortega G; Hernández Calvo J; de la Plaza R; Martín J; López A
Rev Esp Enferm Dig; 2001 Apr; 93(4):260-1. PubMed ID: 11488124
[No Abstract] [Full Text] [Related]
26. Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy.
Shimizu T; Asakuma M; Tomioka A; Inoue Y; Hirokawa F; Hayashi M; Uchiyama K
Am Surg; 2018 Jan; 84(1):109-113. PubMed ID: 29428036
[TBL] [Abstract][Full Text] [Related]
27. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
Klapdor R; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
[No Abstract] [Full Text] [Related]
28. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
29. Transatlantic registries of pancreatic surgery in the United States of America, Germany, the Netherlands, and Sweden: Comparing design, variables, patients, treatment strategies, and outcomes.
Mackay TM; Gleeson EM; Wellner UF; Williamsson C; Busch OR; Groot Koerkamp B; Keck T; van Santvoort HC; Tingstedt B; Pitt HA; Besselink MG;
Surgery; 2021 Feb; 169(2):396-402. PubMed ID: 32868111
[TBL] [Abstract][Full Text] [Related]
30. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?
Miyazaki M; Yoshitomi H; Shimizu H; Ohtsuka M; Yoshidome H; Furukawa K; Takayasiki T; Kuboki S; Okamura D; Suzuki D; Nakajima M
Surgery; 2014 Jan; 155(1):58-66. PubMed ID: 24238124
[TBL] [Abstract][Full Text] [Related]
31. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial.
Mackay TM; Smits FJ; Latenstein AEJ; Bogte A; Bonsing BA; Bos H; Bosscha K; Brosens LAA; Hol L; Busch ORC; Creemers GJ; Curvers WL; den Dulk M; van Dieren S; van Driel LMJW; Festen S; van Geenen EJM; van der Geest LG; de Groot DJA; de Groot JWB; Haj Mohammad N; Haberkorn BCM; Haver JT; van der Harst E; Hemmink GJM; de Hingh IH; Hoge C; Homs MYV; van Huijgevoort NC; Jacobs MAJM; Kerver ED; Liem MSL; Los M; Lubbinge H; Luelmo SAC; de Meijer VE; Mekenkamp L; Molenaar IQ; van Oijen MGH; Patijn GA; Quispel R; van Rijssen LB; Römkens TEH; van Santvoort HC; Schreinemakers JMJ; Schut H; Seerden T; Stommel MWJ; Ten Tije AJ; Venneman NG; Verdonk RC; Verheij J; van Vilsteren FGI; de Vos-Geelen J; Vulink A; Wientjes C; Wit F; Wessels FJ; Zonderhuis B; van Werkhoven CH; van Hooft JE; van Eijck CHJ; Wilmink JW; van Laarhoven HWM; Besselink MG;
Trials; 2020 Apr; 21(1):334. PubMed ID: 32299515
[TBL] [Abstract][Full Text] [Related]
32. Solid pseudopapillary tumor of the pancreas: can malignancy be predicted?
Kim CW; Han DJ; Kim J; Kim YH; Park JB; Kim SC
Surgery; 2011 May; 149(5):625-34. PubMed ID: 21300390
[TBL] [Abstract][Full Text] [Related]
33. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
[TBL] [Abstract][Full Text] [Related]
34. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
35. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.
Versteijne E; van Eijck CH; Punt CJ; Suker M; Zwinderman AH; Dohmen MA; Groothuis KB; Busch OR; Besselink MG; de Hingh IH; Ten Tije AJ; Patijn GA; Bonsing BA; de Vos-Geelen J; Klaase JM; Festen S; Boerma D; Erdmann JI; Molenaar IQ; van der Harst E; van der Kolk MB; Rasch CR; van Tienhoven G;
Trials; 2016 Mar; 17(1):127. PubMed ID: 26955809
[TBL] [Abstract][Full Text] [Related]
36. A false postoperative recurrence of intraductal and papillary mucinous neoplasm of the pancreas.
Ahmed O; Pommier R; Cros J; Sauvanet A
J Visc Surg; 2018 Apr; 155(2):165-166. PubMed ID: 29291923
[TBL] [Abstract][Full Text] [Related]
37. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
[TBL] [Abstract][Full Text] [Related]
38. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
39. Recurrence of Solid Pseudopapillary Neoplasms of the Pancreas: Results of a Nationwide Study of Risk Factors and Treatment Modalities.
Irtan S; Galmiche-Rolland L; Elie C; Orbach D; Sauvanet A; Elias D; Guérin F; Coze C; Faure-Conter C; Becmeur F; Demarche M; Galifer RB; Galloy MA; Podevin G; Aubert D; Piolat C; De Lagausie P; Sarnacki S
Pediatr Blood Cancer; 2016 Sep; 63(9):1515-21. PubMed ID: 27186826
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic pancreaticoduodenectomy for remnant pancreatic recurrence after laparoscopic distal pancreatectomy and hepatectomy for greater omentum leiomyosarcoma.
Nakagawa Y; Fukami Y; Harada T; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y
Asian J Endosc Surg; 2020 Jan; 13(1):117-120. PubMed ID: 30843350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
